MeadowBrook Investment Advisors’s Pfizer PFE Stock Holding History

MeadowBrook Investment Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$408K	Buy	16,932 +240	+1%	+$6.28K	0.32%	71
2026 Q1	$469K	Sell	16,692 -1,465	-8%	-$39K	0.41%	57
2025 Q4	$452K	Sell	18,157 -565	-3%	-$14.2K	0.39%	59
2025 Q3	$477K	Buy	18,722 +1,275	+7%	+$31.5K	0.41%	58
2025 Q2	$423K	Sell	17,447 -1,615	-8%	-$37.7K	0.38%	64
2025 Q1	$483K	Sell	19,062 -200	-1%	-$5.23K	0.45%	53
2024 Q4	$511K	Sell	19,262 -2,257	-10%	-$61.2K	0.45%	51
2024 Q3	$623K	Buy	21,519 +1,696	+9%	+$49.5K	0.56%	44
2024 Q2	$555K	Buy	19,823 +808	+4%	+$22.2K	0.53%	48
2024 Q1	$528K	Buy	19,015 +3,672	+24%	+$102K	0.49%	50
2023 Q4	$442K	Buy	+15,343	New	+$464K	0.42%	60

Other funds holding PFE

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

SLAM

Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

MeadowBrook Investment Advisors's PFE Position: Q2 2026 in Review

MeadowBrook Investment Advisors increased its Pfizer (PFE) stake by 1.4% in Q2 2026, buying an estimated $6.28K and bringing the position to 16,932 shares worth $408K. The position accounts for 0.32% of the portfolio, ranked #71.

MeadowBrook Investment Advisors first reported a position in PFE in Q4 2023 and has held it in 11 quarters since. The position peaked at $623K in Q3 2024. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

MeadowBrook Investment Advisors held 16,932 shares of Pfizer worth $408K as of Q2 2026.
MeadowBrook Investment Advisors bought 240 Pfizer shares in Q2 2026, an estimated $6.28K.
Pfizer made up 0.32% of MeadowBrook Investment Advisors's portfolio in Q2 2026, its #71 holding.
MeadowBrook Investment Advisors first reported a position in Pfizer in Q4 2023 and has held it in 11 quarters since.
MeadowBrook Investment Advisors's Pfizer position peaked at $623K in Q3 2024.
1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on MeadowBrook Investment Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.